Ocularis Pharma is pioneering the development of Nyxol® Eye Drops to improve night vision in people who experience night vision disturbances such as glare, halos and starburst which make night driving difficult. Our goal is to successfully conduct a Phase 2b clinical study with Nyxol which will lead to a partnering deal with an ophthalmic drug company with the ability to conduct a Phase 3 program, obtain FDA approval and commercialize Nyxol.